IMARC Group, a leading market research company, has recently releases report titled Plasma Fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. The study provides a detailed analysis of the industry, including the global plasma fractionation market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is The Plasma Fractionation Market?
The globalplasma fractionationmarket size reached US$ 23.8 Billionin 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
What Are Plasma Fractionation?
Plasma fractionation represents the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma within individual proteins or fractions by using numerous mechanical separation methods, including centrifugation, depth filtration, precipitation, chromatography, etc. Presently, several modern fractionation procedures use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.
What Are The Growth Prospects And Trends In The Plasma Fractionation Industry?
The growing prevalence of congenital deficiencies, blood infections, immunologic and autoimmune disorders, etc., is among the key factors stimulating the plasma fractionation market. Moreover, the escalating demand for this processing with additional safety features, on account of the implementation of stringent regulations and standard controls and settings by governing agencies of various countries on quality assurance of biological products, is propelling the market growth. Besides this, the growing investments in plasma production technology to improve item efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins are acting as significant growth-inducing factors. Furthermore, the rising focus on developing affordable viral inactivation and processing technologies that safely allow local plasma resource utilization is further fueling the global market. Apart from this, the elevating need for improving yield, maintaining process economics, and managing regulatory requirements is positively influencing the market growth. Additionally, numerous favorable government initiatives, such as the launch of awareness programs encouraging blood donation and funding for research and development (RD) activities, are anticipated to fuel the plasma fractionation market over the forecasted period.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
Breakup by Sector:
- Private Sector
- Public Sector
Breakup by Application:
- Neurology
- Immunology
- Hematology
- Other Applications
Breakup by End User:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
- ADMA Biologics
- Bio Products Laboratory Ltd.
- Boccard
- Grifols
- A.
- Hemarus Therapeutics Limited
- Intas Pharmaceuticals Limited
- LFB S.A.
- Merck Group
- Octapharma AGP
- lasmaGen BioSciences Pvt. Ltd.
- SK Plasma Co. Ltd.
- and Virchow Biotech Private Limited.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Groups information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email:sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn:https://www.linkedin.com/company/imarc-group/mycompany/
